SEM of hybridoma cells used in cancer therapy

SEM of hybridoma cells used in cancer therapy

G400/0043 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 51.0MB

Downloadable file size: 2.4MB

Price image Pricing

Please login to use the price calculator


Credit: CNRI/SCIENCE PHOTO LIBRARY

Caption: False-colour scanning electron micrograph (SEM) of hybridoma cells used in production of monoclonal antibodies for cancer therapy. Hybridomas are a combination of cancer cells (myelomas) and lymphocytes, which secrete the antibodies that label malignant cells. Lymphocytes are short- lived once removed from the body, precluding them from further study: cancer cells, however, grow easily in the laboratory. Hence, cells that secrete antibodies can be made immortal by fusing them with tumour cells and cloning the hybrids. Each clone would be a long-term source of quantities of a single, highly specific antibody. Magnification: x1750 at 6x7cm, x875 at 35mm size.

Release details: Model release not required. Property release not required.

Keywords: biotechnology, cancer therapy, drug, engineering, genetic, genetically engineered, genetics, hybridoma, hybridoma cell, monoclonal antibody antibodies

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.